Moderna, Inc. (MRNA) Net income 2016–2025
Moderna, Inc. (MRNA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$2.8BFY2025 · since FY2016: -$216.2M → -$2.8B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.8B | +20.8% |
| FY2024 | -$3.6B | +24.5% |
| FY2023 | -$4.7B | -156.4% |
| FY2022 | $8.4B | -31.5% |
| FY2021 | $12.2B | +1733.5% |
| FY2020 | -$747.0M | -45.3% |
| FY2019 | -$514.0M | -33.6% |
| FY2018 | -$384.7M | -50.3% |
| FY2017 | -$255.9M | -18.4% |
| FY2016 | -$216.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice